Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development.
Sue has served as CEO and Board member of several ASX and NASDAQ listed companies in the healthtech sector. She is current Chair of MTPConnect, a not-for-profit industry growth centre for the medtech, biotech and pharmaceutical sectors. She is also Chair of ASX-listed Anatara Lifesciences Ltd, Tali Digital Ltd and Oventus Medical Ltd, and a non-executive director of Palla Pharma Ltd and veski.
Sue is appointed to several academic and government advisory boards including the Prime Minister’s Digital Expert Advisory Board, CSIRO Health and Biosecurity Advisory Committee, DMTC Medical Countermeasures, Genomics Health Futures Expert Advisory Committee (MRFF) and a number of COVID-19 taskforces.
Her broad commercial and technical experience is underpinned by a Bachelor of Pharmacy from the University of Queensland, a Master of Laws from Deakin University and a Master of Marketing from Melbourne Business School. She is also a Fellow and Chair of the Health Forum at the Australian Academy of Technology and Engineering (ATSE) and Fellow/Graduate of Australian Institute of Company Directors (AICD).